Professional Documents
Culture Documents
Neurologic Disorders Pharm
Neurologic Disorders Pharm
Dosage
Action
Special
Considerat
Anticonvulsants
Phenytoin (Dilantin)
Fosphenytoin
(Cerebyx)
Barbiturates
Phenobarbital
Produces CNS
depression and
reduces the spread of
an epileptic focus
Pentobarbital
Induces barbiturate
coma
--Monitor seru
levels closely
--Therapeutic l
10-20 mg/L (if
hypoalbuminu
monitor free
phenytoin seru
levels: therape
level of 0.1-0.2
--Infuse no fas
than 50 mg/m
administer wit
normal saline
because it
precipitates w
other solutions
--Monitor seru
levels closely;
therapeutic lev
10-20 mg/L.
--Dosage,
concentration
infusion rate is
expressed as
phenytoin sod
equivalents (F
--May depress
and respirator
function
--Administer a
of 60 mg/min
--Monitor seru
closely; --Ther
level is 15-40
--Monitor seru
closely
--Therapeutic l
coma is 15-40
Osmotic Diuretics
Mannitol
1-2 g/kg IV
Treats cerebral
edema by pulling
fluid from the
extravascular space
into the intravascular
space; requires intact
blood-brain barrier
--Side effects:
hypovolemia a
increased seru
osmolality.
--Monitor seru
osmolality and
MD if >310 mO
--Warm and sh
before adminis
to ensure the
dissolve
CCBs
60 mg q 4h NG or PO
Nimodipine (Nimotop) for 21 days
Decreases cerebral
vasospasm
Thrombolytics
Tissue-Type
Plasminogen
Activator (tPA)
Converts
plasminogen to
plasmin to dissolve
clot
--Side effects:
hypotension,
palpitations,
headache, dizz
--Monitor blood
pressure frequ
when impleme
therapy
--Treatment m
start within 4.5
the onset of
symptoms
--Do not excee
mg
--Do not use
anticoagulants
the first 24 hr.
--Monitor patie
bleeding.